It took 20 years for the first antibody drugs to make it from the bench to the pharmacy shelf.

FORBES: Magazine Article

In 1997, it received FDA approval for the first antibody to treat cancer.

FORBES: Genentech Has Success In Its DNA

Now into this gloom comes a new type of drug, called an anti-CD3 antibody, that aims for the first time to delay or prevent development of the devastating disease by arresting the immune system's attack on pancreatic islet cells.

FORBES: Delaying Diabetes

This was controversial at first, but Slamon persuaded Genentech to test a monoclonal antibody that would block this protein.

FORBES: Targeting Tumors

Novartis' promising Muckle-Wells drug--its antibody against interleukin-1, which it first aimed at arthritis--was one of the first drugs to benefit from Fishman's new testing regimen.

FORBES: Magazine Article